Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WHP Omega 3
- Development stage
- Phase 1
- Lead developer
- Homeosyn Italia
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
WHP Omega 3 is a nutraceutical dietary supplement developed by Homeosyn Italia, formulated as oral softgels (perles). It contains a 72.4% concentration of fish oil, providing a 50% concentration of the omega-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The product is indicated for the management of dyslipidemia and lipid metabolism disorders due to its ability to lower cholesterol and normalize triglyceride levels. Its mechanism involves the activation of prostaglandins and acting as a natural antioxidant. It is also utilized as an adjuvant in antihypertensive therapy and is marketed through pharmacies in Italy.
- Brand names
- WHP Omega 3WHP OMEGA-3 30 Perle
- Other names
- omega-3 supplementomega3 supplementomega 3 supplement
02
Targets
PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)PPARD (Peroxisome proliferator–activated receptor delta)
Beyond the preview
Go deeper on WHP Omega 3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WHP Omega 3.